When Pain Conditions Precede IBD: What a 2026 Systematic Review Reveals

Many people who receive an inflammatory bowel disease diagnosis have spent years before it navigating a different set of diagnoses. Irritable bowel syndrome is the most common, but chronic pelvic pain, endometriosis, interstitial cystitis, fibromyalgia, and related conditions are frequently part of the history too. For a long time, this pattern was largely attributed to diagnostic uncertainty or coincidence. A 2026 systematic review set out to examine it more rigorously, asking whether these chronic overlapping pain conditions are genuinely predisposing or perpetuating factors for IBD.

What Are Chronic Overlapping Pain Conditions?

Chronic overlapping pain conditions (COPCs) are a cluster of conditions characterised by persistent pain that does not have a straightforward structural explanation. They include:

• Irritable bowel syndrome (IBS): abdominal pain and altered bowel habit without visible inflammation
• Endometriosis: tissue similar to the uterine lining growing outside the uterus, causing pelvic pain
• Interstitial cystitis and bladder pain syndrome: chronic bladder pain and urinary urgency without infection
• Fibromyalgia: widespread musculoskeletal pain, fatigue, and sleep disturbance
• Vulvodynia and chronic pelvic pain: persistent pelvic or genital pain without a fully identifiable structural cause

What links these conditions is that they co-occur more often than chance would predict. A person with IBS has a higher-than-expected likelihood of also carrying a fibromyalgia or endometriosis diagnosis. The proposed shared mechanisms include central sensitisation, a state in which the nervous system becomes persistently amplified in its pain responses, as well as altered gut-brain signalling and similar patterns of immune and microbiome disruption.

IBD has historically been considered separately: it is an autoimmune, structurally visible disease with identifiable bowel inflammation that can be confirmed on endoscopy. But the lived experience of patients has long suggested a closer relationship between these conditions.

The 2026 Systematic Review

A systematic review published in May-June 2026 in Revista Espanola de Enfermedades Digestivas (pubmed:42494170) specifically examined whether gastrointestinal, gynaecological, and urogenital COPCs act as predisposing or perpetuating factors for inflammatory bowel disease. The review gathered and assessed the available literature on how this cluster of conditions relates to IBD, examining whether COPCs appear before IBD diagnosis at higher rates than expected, and whether they continue to influence disease course once IBD is established.

The review found evidence supporting a significant bidirectional association between COPCs and IBD. People with existing COPCs carry higher rates of IBD than general population controls. Conversely, people with established IBD carry substantially higher rates of COPCs than general population comparison groups. The evidence supported the view that this relationship is not simply one of misdiagnosis, where IBS is confused with IBD, but one of genuine clinical overlap: these conditions can genuinely coexist, and having one may increase the likelihood of developing, or being assessed for, the other.

The review also addressed the perpetuating direction: COPCs appear to worsen the IBD experience once both are present. Their presence was associated with worse perceived disease activity, poorer quality of life, and more frequent reporting of gastrointestinal symptoms even in periods when endoscopy showed controlled disease. The authors concluded that COPCs represent a clinically relevant comorbidity cluster in IBD that warrants routine recognition, and that their presence may help explain the disconnect some patients experience between their test results and their daily symptoms.

IBD and IBS Are Different, But Not Always Unrelated

The NHS makes clear that irritable bowel syndrome and inflammatory bowel disease are distinct conditions. IBS is a functional disorder characterised by symptoms without visible inflammation; IBD is an immune-mediated condition involving measurable damage to the bowel lining, visible on endoscopy or imaging. They require different investigations, different treatments, and carry different long-term prognoses.

At the same time, the NHS acknowledges that IBS symptoms and IBD symptoms overlap considerably, particularly abdominal pain, urgency, and altered bowel habit. This overlap makes clinical assessment more complex, especially in people who present for the first time or whose IBD is in remission but whose symptoms persist.

What the 2026 systematic review adds is a framework for understanding why these conditions appear together so often. The evidence it synthesises suggests that the shared biology is real: central sensitisation, altered gut-brain axis signalling, and immune dysregulation may connect IBD and the broader COPC cluster at a mechanistic level. This is not yet a complete explanation, and the field is still mapping the precise relationships, but it moves the question from coincidence toward biology.

What This Means for Patients

The practical implication of this evidence is not that every chronic pain condition signals IBD, or that an IBD diagnosis makes other pain conditions invalid. It is that these conditions frequently coexist, and that coexistence matters for how IBD is understood and managed.

For patients who spent years with IBS, endometriosis, or pelvic pain diagnoses before receiving an IBD diagnosis, the research provides grounding: the symptoms were real, and they may reflect connected processes rather than separate and unrelated conditions. For patients with established IBD who continue to experience pain or gastrointestinal symptoms despite controlled disease on investigation, the research supports an honest conversation with a gastroenterologist or IBD nurse about whether a coexisting COPC is contributing.

Clinical recognition of this overlap also matters for care. A team that understands COPCs are common in IBD patients is better placed to interpret symptom reports accurately, assess quality of life comprehensively, and avoid attributing all symptoms to a single cause when the picture may be more layered.